Participants are randomised to agent A or agent B within one trial, so the arms differ only in the agent. The result is a direct estimate of the difference between them in that population. The Lancet 2023 retatrutide trial contained one such comparison, against dulaglutide.
This design is costly and sponsors choose comparators carefully, which is why direct comparisons against the strongest competitor are rare.
If A has been compared with placebo and B has been compared with placebo in separate trials, the two placebo-controlled results can be combined to estimate A against B. A network extends this across many trials and agents. The method is established and widely used in health technology assessment.
Its reliability depends on the connected trials being similar in population and design — the transitivity assumption — and its estimates carry wider confidence intervals than direct comparisons.
A direct comparison supports a statement about A versus B in that trial. A network estimate supports a probabilistic statement with stated uncertainty. A headline figure placed beside another supports nothing. The retatrutide literature contains the first kind once and, as of this page, published network analyses that include it should be read with their stated uncertainty.
Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.
| Format | Strength | Price | Availability |
|---|---|---|---|
| Retatrutide Pack | 20 mg | AED 1010 | In stock |
Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.
Participants are randomised to agent A or agent B within one trial, so the arms differ only in the agent. The result is a direct estimate of the difference between them in that population. The Lancet 2023 retatrutide trial contained one such comparison, against dulaglutide.
No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.
Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.
Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.